Accelerated Wound Healing by Fibroblasts Differentiated from Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells in a Pressure Ulcer Animal Model

<div>Arrangement of hESC-MSC-Fbs at the wound site after three ischemia/reperfusion (I/R) cycles. (a) Wounded skin after treatment with phosphate-buffered saline (PBS), human embryonic stem cell-derived mesenchymal stem cells (hESC-MSCs), or hESC-MSC-derived fibroblasts (hESC-MSC-Fbs) at 12 days after three I/R cycles was observed under fluorescent microscopy for the detection of DiI. (b) Wounded skin after treatment with PBS, hESC-MSCs, or hESC-MSC-Fbs at 12 days after three I/R cycles was immunostained for the detection of <i>α</i>-SMA. 4′,6′-Diamidino-2-phenylindole was used for nuclear counterstaining.</div>

Stem Cells International

fig3

Figure 3

Figure 3: Accelerated Wound Healing by Fibroblasts Differentiated from Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells in a Pressure Ulcer Animal Model 

Figure 3 | Accelerated Wound Healing by Fibroblasts Differentiated from Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells in a Pressure Ulcer Animal Model 